Advanced search
Start date
Betweenand


The pro-apoptotic effect of human amylin oligomers is not potentiated by lipotoxicity in rat pancreatic islets in culture

Full text
Author(s):
Érika Rodrigues de Oliveira
Total Authors: 1
Document type: Master's Dissertation
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Faculdade de Medicina (FM/SBD)
Defense date:
Examining board members:
Maria Lucia Cardillo Correa Giannella; Adriana Ribeiro Leite; Marisa Passarelli
Advisor: Maria Lucia Cardillo Correa Giannella
Abstract

The amyloid deposit is a common histopathological feature in patients with type 2 diabetes mellitus (T2DM) and it seems to be related to the pancreatic beta cell dysfunction characteristic of this disease. A study previously developed in our laboratory found that human amylin oligomers decrease mRNA expression of the glucose-dependent insulinotropic polypeptide receptor (Gipr) and increase apoptosis rate in rat pancreatic islets maintained in culture. Considering the important role of the amyloid deposition and of incretins in the pathophysiology of T2DM, the aims of the present study were to investigate (1) the effect of human amylin on the expression of incretin receptors and (2) the modulation of amylin toxicity by other concomitant conditions present in T2DM, as lipotoxicity and advanced glycation end products (AGEs). The evaluation of mRNA expression of Gipr and Glp1r (glucagonlike peptide -1 receptor) was performed by real time PCR in islets exposed only to human amylin oligomers (10 M) for 4 and 8 h, and in islets exposed to human amylin and palmitate (0,5 mM) for 24 and 48 h; GIPR and GLP1R protein expression was assessed by Western blot in islets treated with amylin oligomers by 12 h; apoptosis rate was evaluated by measuring caspase 3 activity in islets treated with amylin alone or combined to palmitate (0,5 mM) for 48 h or 5 mg/mL of glycated albumin (AlbGAD) for 72 h. Amylin did not affect the expression of Gipr and Glp1r mRNA following 4 h of exposure. Eight and 24 h after treatment, amylin negatively modulated the expression of these genes. However, treatment of the islets for 48 h with amylin elicited an increase in mRNA expression of both incretin receptors. The simultaneous treatment with palmitate did not change the effects of amylin on the expression of Gipr and Glp1r mRNA after 24 and 48 h. Exposure of islets to amylin for 12 h caused no change in GIPR and GLP1R protein expression. Lipotoxocity and glycated albumin did not increase the pro-apoptotic effect of amylin on pancreatic islets. In conclusion, the reduction in mRNA expression of the incretin receptors on rat pancreatic islets exposed to amylin, which could indicate an additional mechanism whereby amylin exert its deleterious effect on beta cells, reducing the insulinotropic effects of incretins in patients with T2DM was not confirm regarding GIPR and GLP1R protein expression at the time period studied. The increased mRNA expression of these receptors caused by amylin after 48 h of incubation could be a compensation mechanism against the toxic effects of amylin oligomers. The pro-apoptotic effect of amylin on human beta cells does not appear to be potentiated by lipotoxicity or by advanced glycation end products (AU)

FAPESP's process: 09/03775-8 - Evaluation of the expression of incretin receptors in rat pancreatic islets exposed to human amylin and to lipotoxicity.
Grantee:Erika Rodrigues de Oliveira
Support Opportunities: Scholarships in Brazil - Master